HB 102

  • Virginia House Bill
  • 2022 Regular Session
  • Introduced in House Jan 06, 2022
  • Passed House Feb 14, 2022
  • Senate
  • Governor

Prescriptions; off-label use.

Abstract

Prescriptions; off-label use. Provides that a prescriber may prescribe, administer, or dispense and a pharmacist may dispense a drug that has been approved for a specific use by the U.S. Food and Drug Administration for an off-label use when the prescriber or pharmacist determines, in his professional judgment, that such off-label use is appropriate for the standard of care and such prescribing, administering, or dispensing is to improve health care outcomes. The bill also prohibits a hospital from denying, revoking, terminating, diminishing, or curtailing in any way any professional or clinical privilege of any licensed health care provider with prescriptive authority or authority to dispense drugs solely on the grounds that such health care provider prescribes, administers, or dispenses a drug that has been approved for a specific use by the U.S. Food and Drug Administration for an off-label use, provided that such prescribing, administering, or dispensing is in accordance with laws of the Commonwealth and is to improve health care outcomes.

Prescriptions; off-label use. Provides thata licensed health care provider with prescriptive authority may prescribe,administer, or dispense a drug that has been approved for a specificuse by the U.S. Food and Drug Administration for an off-label usewhen the health care provider determines, in his professional judgement,that such off-label use is appropriate for the care and treatmentof the patient, and prohibits a pharmacist from refusing to dispensea drug for off-label use if a valid prescription is presented. The bill also requires the Board of Health to include in regulationsgoverning hospitals a provision that no hospital shall deny, revoke,terminate, diminish, or curtail in any way any professional or clinicalprivilege to a health care provider with prescriptive authority solelyon the grounds that such health care provider prescribes, administers,or dispenses a drug that has been approved for a specific use bythe U.S. Food and Drug Administration for an off-label use.

Bill Sponsors (8)

Votes


Actions


Feb 24, 2022

Senate

Passed by indefinitely in Education and Health (8-Y 7-N)

Feb 16, 2022

Senate

Referred to Committee on Education and Health

Senate

Constitutional reading dispensed

Feb 14, 2022

House

Read third time and passed House (52-Y 46-N)

House

VOTE: Passage (52-Y 46-N)

Feb 11, 2022

House

Read second time

House

Engrossed by House - committee substitute HB102H1

House

Committee substitute agreed to 22104743D-H1

Feb 10, 2022

House

Read first time

Feb 09, 2022

House

Impact statement from DPB (HB102H1)

Feb 08, 2022

House

Reported from Health, Welfare and Institutions with substitute (12-Y 10-N)

House

Committee substitute printed 22104743D-H1

House

House committee, floor amendments and substitutes offered

Feb 01, 2022

House

Subcommittee recommends reporting with substitute (5-Y 4-N)

House

House subcommittee amendments and substitutes offered

Jan 18, 2022

House

Assigned HWI sub: Subcommittee #1

Jan 13, 2022

House

Impact statement from DPB (HB102)

Jan 06, 2022

House

Referred to Committee on Health, Welfare and Institutions

House

Prefiled and ordered printed; offered 01/12/22 22103672D

Bill Text

Bill Text Versions Format
Prefiled and ordered printed; offered 01/12/22 22103672D PDF HTML
Committee substitute printed 22104743D-H1 PDF HTML

Related Documents

Document Format
Fiscal Impact Statement: HB102FH1122.PDF PDF
Fiscal Impact Statement: HB102F122.PDF PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Virginia General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.